Medical Affairs Advisor of Hamburg
During his study of biology Dan Seiler worked as a member of the nursing staff at Kiel University hospital. Post-graduate he quit this job to accept a position in the special research division 313 at Kiel University. After obtaining his Ph.D. in 1999 he worked short time as a medical sales representative. In order to place more emphasis on academic work he then became an academic assistant and project manager at different CROs where he was responsible for all aspects of phase I clinical trials according to GCP standard. He also managed HPLC and LC/MS/MS analyses according to GLP standard of both clinical and toxicological studies. Dan Seiler is currently working as a medical advisor at Helm AG, a company specialized in chemicals which also develops generic products. There he supports project teams with scientific advice and is responsible for the conduct of clinical studies. He prepares clinical and non-clinical expert statements and replies to question raised by regulatory authorities.
Dan Seiler is member of the EGA (European Generic Association) bioequivalence working group.
Study designs, pharmacokinetics, interpretations of guidelines